These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 9463982)
1. Do prescribing formularies help GPs prescribe from a narrower range of drugs? A controlled trial of the introduction of prescribing formularies for NSAIDs. Avery AJ; Walker B; Heron T; Teasdale SJ Br J Gen Pract; 1997 Dec; 47(425):810-4. PubMed ID: 9463982 [TBL] [Abstract][Full Text] [Related]
2. Determinants of the range of drugs prescribed in general practice: a cross-sectional analysis. de Bakker DH; Coffie DS; Heerdink ER; van Dijk L; Groenewegen PP BMC Health Serv Res; 2007 Aug; 7():132. PubMed ID: 17711593 [TBL] [Abstract][Full Text] [Related]
3. Non-steroidal anti-inflammatory drug prescribing patterns in general practice: comparison of a general practitioner-based survey and a pharmacy-based survey in France. Clinard F; Sgro C; Bardou M; Dumas M; Hillon P; Bonithon-Kopp C Pharmacoepidemiol Drug Saf; 2001; 10(4):329-38. PubMed ID: 11760495 [TBL] [Abstract][Full Text] [Related]
4. Quality of non-steroidal anti-inflammatory drug prescribing in Croatia (Rijeka) and Sweden (Stockholm). Vlahovic-Palcevski V; Wettermark B; Bergman U Eur J Clin Pharmacol; 2002 Jun; 58(3):209-14. PubMed ID: 12107607 [TBL] [Abstract][Full Text] [Related]
5. Personal formularies. An index of prescribing quality? Robertson J; Fryer JL; O'Connell DL; Smith AJ; Henry DA Eur J Clin Pharmacol; 2001 Jul; 57(4):333-41. PubMed ID: 11549213 [TBL] [Abstract][Full Text] [Related]
6. Long-term NSAID use in primary care: changes over a decade and NICE risk factors for gastrointestinal adverse events. Thompson PW; Tee L; McBride J; Quincey D; Strat Liddiard G Rheumatology (Oxford); 2005 Oct; 44(10):1308-10. PubMed ID: 15972345 [TBL] [Abstract][Full Text] [Related]
7. Investigation of whether on-site general practice counsellors have an impact on psychotropic drug prescribing rates and costs. Sibbald B; Addington-Hall J; Brenneman D; Freeling P Br J Gen Pract; 1996 Feb; 46(403):63-7. PubMed ID: 8855009 [TBL] [Abstract][Full Text] [Related]
8. Motivations and perceived influences on rural and urban general practitioners when prescribing conventional non-steroidal anti-inflammatory drugs or COX-2 inhibitors. Behan K; Cutts C; Tett SE J Clin Pharm Ther; 2005 Aug; 30(4):337-43. PubMed ID: 15985047 [TBL] [Abstract][Full Text] [Related]
9. Factors affecting feasibility and acceptability of a practice-based educational intervention to support evidence-based prescribing: a qualitative study. Watkins C; Timm A; Gooberman-Hill R; Harvey I; Haines A; Donovan J Fam Pract; 2004 Dec; 21(6):661-9. PubMed ID: 15528289 [TBL] [Abstract][Full Text] [Related]
10. Uptake of COX-2 selective inhibitors and influence on NSAID prescribing in Northern Ireland. Girvin B; Rafferty T; Stevenson MR; Johnston GD Pharmacoepidemiol Drug Saf; 2004 Mar; 13(3):153-7. PubMed ID: 15072114 [TBL] [Abstract][Full Text] [Related]
11. The prescribing and adverse reactions of nonsteroidal antiinflammatory drugs in general practice: a Dunedin study. Taylor D; Clark DW; Dovey SM; Tilyard MW N Z Med J; 1994 Jul; 107(981):263-6. PubMed ID: 8022581 [TBL] [Abstract][Full Text] [Related]
12. A qualitative study to explore influences on general practitioners' decisions to prescribe new drugs. Jacoby A; Smith M; Eccles M Br J Gen Pract; 2003 Feb; 53(487):120-5. PubMed ID: 12817357 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of an educational-outreach service for community medical practitioners: non-steroidal anti-inflammatory drugs. May FW; Rowett DS; Gilbert AL; McNeece JI; Hurley E Med J Aust; 1999 May; 170(10):471-4. PubMed ID: 10376022 [TBL] [Abstract][Full Text] [Related]
14. Utilization of non-steroidal anti-inflammatory drugs in Quebec: adherence to the Canadian consensus on prescription guidelines. Moride Y; Ducruet T; Boivin JF; Lavoie F; Rochon S Can J Clin Pharmacol; 2005; 12(2):e201-11. PubMed ID: 15998959 [TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal anti-inflammatory drugs and potential risks in a convenience sample of general practitioners. Cutts C; LaCaze A Aust Fam Physician; 2002 Jun; 31(6):590-2. PubMed ID: 12154611 [TBL] [Abstract][Full Text] [Related]
16. Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study. Moride Y; Ducruet T; Boivin JF; Moore N; Perreault S; Zhao S Arthritis Res Ther; 2005; 7(2):R333-42. PubMed ID: 15743481 [TBL] [Abstract][Full Text] [Related]
17. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits. Cook JC; Jacobson CF; Gao F; Tassinari MS; Hurtt ME; DeSesso JM Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):5-26. PubMed ID: 12852480 [TBL] [Abstract][Full Text] [Related]
18. What happened to the prescribing of other COX-2 inhibitors, paracetamol and non-steroidal anti-inflammatory drugs when rofecoxib was withdrawn in Australia? Barozzi N; Tett SE Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1184-91. PubMed ID: 17636557 [TBL] [Abstract][Full Text] [Related]
19. Setting standards of prescribing performance in primary care: use of a consensus group of general practitioners and application of standards to practices in the north of England. Bateman DN; Eccles M; Campbell M; Soutter J; Roberts SJ; Smith JM Br J Gen Pract; 1996 Jan; 46(402):20-5. PubMed ID: 8745847 [TBL] [Abstract][Full Text] [Related]
20. Antihypertensive drug prescribing in Grampian. Ross S; Macleod MJ Br J Clin Pharmacol; 2005 Sep; 60(3):300-5. PubMed ID: 16120069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]